Tag Archives: National Health Service

How can A&E units improve their performance?

The first point that I must make is that I do not wish to appear unappreciative or condescending. Hospital A&E work is amongst the most important that any person can undertake and many of us would find the strain unbearable. … Continue reading

Posted in A&E, Department of Health, Elderly, GPs, Hospitals, NHS, Patients | Tagged , , , , , , , , , , , , , ,

Hospital inspections: lessons to be learnt

The programme of independent hospital inspections carried out by the Care Quality Commission (CQC) was made tougher in September 2013. During the first year to the end of August 2014 under the new arrangements 38 NHS acute trusts (each comprising … Continue reading

Posted in A&E, Department of Health, Health and Wellbeing, Health reform, Hospitals, Local Authorities, NHS, NHS England, NHS reforms, Patient choice, Patients, Quality and Safety, safety, Uncategorized | Tagged , , , , , , , , , , , , ,

Medical advisory body “NICE” should not spend too much time valuing drugs.

The UK National Institute for Health and Care Excellence (“NICE”) is currently holding a public consultation over its proposals for evaluating drugs. Drugs that are approved by NICE automatically become available for doctors to prescribe under the NHS throughout England … Continue reading

Posted in Business, CCGs, Commissioning, Department of Health, Drugs, Elderly, equality, Genetics, GPs, Health and Wellbeing, Health Bill, Health reform, Inequality, Innovation, Jeremy Hunt, NHS, NHS reforms, Patients, Pharma, Policy, Public Health, Research, Technology, Uncategorized, Wellbeing | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot: Negotiations with the UK Government over pharmaceutical pricing have achieved a good result for patients, the NHS and the industry.

The UK Government and the pharmaceutical industry shared many objectives throughout the recent drug pricing negotiations. For example, there was always broad agreement that: The total future drug bill needed to be affordable in the context of other spending in … Continue reading

Posted in Andrew Lansley, Business, Cancer, Department of Health, Drugs, Innovation, Jeremy Hunt, NHS, Patients, Pharma, Research, Smoking ban | Tagged , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Is “listening” the key to reducing antibiotic prescribing?

Wednesday will see the publication of a report on GPs over-prescribing antibiotics for patients – nothing new there – but this has a twist: GPs over-prescribing antibiotics even when the patients are not particularly asking for them. This comes at … Continue reading

Posted in Drugs, Patients | Tagged , , , , , , , , , , | Leave a comment

2020health calls for care.data to be postponed and replaced by an opt-in system

We had a huge amount of interest in our fringe event held on Tuesday at the Conservative Party Conference on privacy and electronic health records. We are vocal advocates of electronic health records (EHR) and the potential for technology to … Continue reading

Posted in Candour, Commissioning, NHS IT, Technology | Tagged , , , , , , , , , , , , , | Leave a comment

Adapting to new technologies; making the big changes to delivery of care

Contribution to 2020health’s recent report ‘Too posh to wash? Reflections on the future of nursing’ By Samantha Walker, RGN PhD, Executive Director, Research & Policy, Asthma UK Adapting to uncertainty Now that the Health Bill has passed into the statute books (Department … Continue reading

Posted in Francis report, Mid-Staffordshire, Nursing | Tagged , , , , , , , | Leave a comment